Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Alembic Pharmaceuticals Ltd (ALEM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
935.50 -9.05    -0.96%
10:58:48 - Closed. Currency in INR ( Disclaimer )
  • Volume: 2,429
  • Bid/Ask: 934.00 / 950.00
  • Day's Range: 933.95 - 953.00
Type:  Equity
Market:  India
ISIN:  INE901L01018 
S/N:  APLLTD
Alembic Pharmaceuticals Ltd 935.50 -9.05 -0.96%

ALEM Income Statement & Profits

 
Assess the Alembic Pharmaceuticals Ltd income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 16305.7 15949.3 14861.5 14064.5
Revenue 16305.7 15949.3 14861.5 14064.5
Other Revenue, Total - - - -
Cost of Revenue, Total 4607.6 4614.3 4135.2 4984.6
Gross Profit 11698.1 11335 10726.3 9079.9
Total Operating Expenses 14336.5 14542.4 13536.4 12635
Selling/General/Admin. Expenses, Total 3492.8 3469.9 3481.7 3039.2
Research & Development 1144.8 1211.3 1177.5 2803.1
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating -151.7 -156.9 -143.9 -143.7
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 5243 5403.8 4885.9 1951.8
Operating Income 1969.2 1406.9 1325.1 1429.5
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -39.5
Other, Net 123.4 60.5 27.6 307.2
Net Income Before Taxes 1845.8 1346.4 1297.5 1161.8
Provision for Income Taxes 41.3 -19.2 91.5 -364.2
Net Income After Taxes 1804.5 1365.6 1206 1526
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1804.5 1365.6 1206 1526
Total Extraordinary Items - - - -
Net Income 1804.5 1365.6 1206 1526
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1804.5 1365.6 1206 1526
Dilution Adjustment - - - -
Diluted Net Income 1804.5 1365.6 1206 1526
Diluted Weighted Average Shares 196.57 196.49 196.42 196.65
Diluted EPS Excluding Extraordinary Items 9.18 6.95 6.14 7.76
DPS - Common Stock Primary Issue - - - 8
Diluted Normalized EPS 5.87 4.28 4.13 3.77
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALEM Price Commentary

Write your thoughts about Alembic Pharmaceuticals Ltd-BO
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mudassar Khan
Mudassar Khan Aug 03, 2021 12:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good opportunity to buy fundamental strong
Jaagrat Sanadhyya
Jaagrat Sanadhyya Sep 12, 2018 7:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it can correct but still very bullish
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email